Searched for
HEALTHCARE MARKET
Anti-cancer medicines: How to protect the patient today without weakening India's healthcare capacity for tomorrowIndia should examine trade margins across medicines, medical devices and consumables using a common, scientifically credible method - not a...- Shukra Medtech, Laurus Labs among 4 healthcare stocks to hit 52-week highs and rally up to 26% in a monthThe Sensex surged 905 points to close at 74,151, while four healthcare stocks hit fresh 52-week highs. Shukra Medtech, Acutaas Chemicals, P...
- Global Market: Malaysia's Asia OneHealthcare files draft prospectus for IPO of up to 4.38 billion sharesMalaysian hospital operator Asia OneHealthcare has filed for an IPO of up to 4.38 billion shares on Bursa Malaysia. The TPG-backed company ...
- Reckitt’s base effect GST boost in India to unwind in Q4, says CEOReckitt's India operations showed strong growth momentum in the July-September quarter compared to the previous year. The prior year was af...
- US midterm elections 2026: Iowa’s 3rd District tests whether Democrats can win back Trump voters againIowa 3rd District election 2026: Iowa’s 3rd Congressional District has become a closely watched House race, with Republican Zach Nunn facin...
- Paras Healthcare shares to list today: Check GMP ahead of debutThe Rs 1,450-crore IPO comprised a fresh issue of 72.15 lakh shares worth Rs 500 crore and an offer for sale (OFS) of 1.37 crore shares agg...
- VCs go deep on single-specialty healthcare with orthopaedics, pain relief betsThe trend is reflected in several recent funding deals. Bengaluru-based Lumov, which makes orthotic products, is in talks to raise Rs 32 cr...
- Indira IVF in talks to acquire Sabine in nearly Rs 1,300 crore dealIndira IVF is considering an acquisition of Sabine Hospital and Research Centre valued at ₹1,200-1,300 crore. Sabine provides a range of fe...
- Sakar Healthcare posts Rs 11 cr profit in Q2The company said the second quarter growth was supported by new oncology approvals, strong demand across geographies, a better oncology mix...
- Mankind Pharma shares key business developments from Q2 & H1 of FY27The company outperformed the market by 1.1 times in both chronic and acute therapies. Cardiac and anti-diabetes brands registered growth of...
- Lord’s Mark Industries Limited becomes Asia’s first company to secure multiple US FDA registrations for 200+ surgical and hygiene products; US exports to begin in DecemberSilvassa manufacturing expansion completed ahead of schedule as the company prepares to expand its international footprint across the Unite...
- Paras Healthcare allotment likely today: Check GMP, key details and how to check statusParas Healthcare IPO allotment is expected to be finalised today after the Rs 1,450-crore issue was subscribed 2.23 times. With the GMP ind...
- Union Minister Piyush Goyal interacts with Indian diaspora in Germany, lauds contribution to 'Karmabhoomi'Union Minister of Commerce and Industry Piyush Goyal held an insightful interaction with members of the Indian diaspora in Germany, lauding...
- Commerce minister Piyush Goyal discusses investment avenues with German companiesPiyush Goyal engaged with major German firms like Siemens Healthineers, Bayer, and Fresenius to discuss investments. He highlighted Bayer's...
- Indian pharma: Unethical practices, marketing rules under lens; new review body set upThe review comes against the backdrop of the Uniform Code for Pharmaceutical Marketing Practices (UCPMP), which was introduced in 2015 as a...
- Paras Healthcare IPO Day 3: Check GMP, subscription status and key detailsParas Healthcare’s Rs 1,450 crore IPO enters its final bidding day with a muted response, while a grey market premium of around 2% signals ...
- Piyush Goyal discusses investment opportunities with Bayer, FreseniusPiyush Goyal held meetings with Bayer and Fresenius executives to discuss investment opportunities in India's healthcare sector. During the...
- US stocks 2026: Moderna, SanDisk lead top 10 gainers delivering up to 734% returnsTen US stocks with market caps above $5 billion have seen share prices more than triple in 2026, delivering returns up to 734%. Healthcare ...
- Paras Healthcare IPO opens for subscription: Check GMP, price band and key detailsParas Healthcare’s Rs 1,450 crore IPO opened for subscription on October 21 and closes on October 23, with a grey market premium (GMP) of a...
- Wipro GE HealthCare considering fifth India plant, plans to double exportsWipro GE HealthCare is evaluating options for a new manufacturing facility in India to enhance operations. The company operates four plants...
Load More
